Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia

Abstract Docetaxel is a major anticancer drug that can induce hypersensitivity reactions leading to deleterious treatment interruptions. Blood hypereosinophilia could be a biological sign, potentially lethal, of delayed visceral hypersensitivity reactions. We hypothesized this biological event is pr...

Full description

Bibliographic Details
Main Authors: Diaddin Hamdan, Christophe Leboeuf, Christine Le Foll, Guilhem Bousquet, Anne Janin
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2062